bgcolor="#ffffff" align="center" colspan="2" |
Bumetanide |
align="center" colspan="2" | 3-(aminosulfonyl)-5-(butylamino)-
4-phenoxybenzoic acid |
CAS number
28395-03-1 | ATC code
C03CA02 |
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | CHNOS |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 364.42 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | almost complete |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | hepatic |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | 60-90 minutes |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | renal |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | C (Australia) |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | S4 (Aust)
POM (UK) |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | oral |